DCMA is phenotypically related to Barth syndrome (3-methylglutaconic aciduria type II) which is caused by mutations in the X-linked TAZ gene and whose clinical features partially overlap those seen in DCMA (10, 11). This evidence concerns the gene TAFAZZIN and Barth syndrome.